Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 121485
Published online Nov 15, 2026. doi: 10.4251/wjgo.121485
Published online Nov 15, 2026. doi: 10.4251/wjgo.121485
Table 3 Multivariate analyses of overall survival in intrahepatic cholangiocarcinoma patients
| Variables | Factors | β | SE | Wald | P value | HR (95%CI) |
| Differentiation degree | Well, moderately/poorly | 0.610 | 0.349 | 3.045 | 0.081 | 1.840 (0.928-3.650) |
| Surgical margin | Negative/positive | 0.416 | 0.588 | 0.501 | 0.479 | 1.516 (0.479-4.800) |
| Vascular invasion | No/yes | 0.713 | 0.323 | 4.869 | 0.027 | 2.040 (1.083-3.844) |
| HMGA2 | Negative/positive | 0.820 | 0.342 | 5.769 | 0.016 | 2.271 (1.163-4.437) |
- Citation: Zhang YN, Hao JY, Lei X, Wang PF, Xu SC, Huang XJ. HMGA2 promotes epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via transforming growth factor-β/small mothers against decapentaplegic 2. World J Gastrointest Oncol 2026; 18(11): 121485
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/121485.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121485